156 related articles for article (PubMed ID: 17290045)
21. Chlamydophila pneumoniae induces expression of toll-like receptor 4 and release of TNF-alpha and MIP-2 via an NF-kappaB pathway in rat type II pneumocytes.
Wissel H; Schulz C; Koehne P; Richter E; Maass M; Rüdiger M
Respir Res; 2005 Jun; 6(1):51. PubMed ID: 15935092
[TBL] [Abstract][Full Text] [Related]
22. Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes.
Liu R; Moroi M; Yamamoto M; Kubota T; Ono T; Funatsu A; Komatsu H; Tsuji T; Hara H; Hara H; Nakamura M; Hirai H; Yamaguchi T
Int Heart J; 2006 Jul; 47(4):511-9. PubMed ID: 16960406
[TBL] [Abstract][Full Text] [Related]
23. Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease.
Lim C; Hammond CJ; Hingley ST; Balin BJ
J Neuroinflammation; 2014 Dec; 11():217. PubMed ID: 25540075
[TBL] [Abstract][Full Text] [Related]
24. Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms.
Berenson CS; Kruzel RL; Wrona CT; Mammen MJ; Sethi S
PLoS One; 2015; 10(9):e0134209. PubMed ID: 26361369
[TBL] [Abstract][Full Text] [Related]
25. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations.
Lieberman D; Ben-Yaakov M; Lazarovich Z; Ohana B; Boldur I
Eur J Clin Microbiol Infect Dis; 2001 Oct; 20(10):698-704. PubMed ID: 11757970
[TBL] [Abstract][Full Text] [Related]
26. [Chlamydia pneumoniae infections].
Miyashita N
Kekkaku; 2006 Sep; 81(9):581-8. PubMed ID: 17037392
[TBL] [Abstract][Full Text] [Related]
27. Chlamydia pneumoniae and COPD exacerbation.
Seemungal TA; Wedzicha JA; MacCallum PK; Johnston SL; Lambert PA
Thorax; 2002 Dec; 57(12):1087-8; author reply 1088-9. PubMed ID: 12454307
[No Abstract] [Full Text] [Related]
28. The Impact of Exogenous Factors on Respiratory Pathogen-Induced Innate Alveolar Macrophage Responses in COPD.
Berenson CS; Kruzel RL; Sethi S
Immunol Invest; 2016; 45(2):130-47. PubMed ID: 26853802
[TBL] [Abstract][Full Text] [Related]
29. Infections caused by Chlamydophila pneumoniae.
Choroszy-Król I; Frej-Mądrzak M; Hober M; Sarowska J; Jama-Kmiecik A
Adv Clin Exp Med; 2014; 23(1):123-6. PubMed ID: 24596014
[TBL] [Abstract][Full Text] [Related]
30. CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent.
Tvinnereim A; Wizel B
J Immunol; 2007 Sep; 179(6):3947-57. PubMed ID: 17785832
[TBL] [Abstract][Full Text] [Related]
31. [Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease].
Duan Z; Liu S; Wang B
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):208-11. PubMed ID: 11802964
[TBL] [Abstract][Full Text] [Related]
32. Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction.
Harada K; Isse K; Nakanuma Y
J Clin Pathol; 2006 Feb; 59(2):184-90. PubMed ID: 16443736
[TBL] [Abstract][Full Text] [Related]
33. The association of Chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies.
Khoshbayan A; Taheri F; Moghadam MT; Chegini Z; Shariati A
Microb Pathog; 2021 May; 154():104803. PubMed ID: 33609645
[TBL] [Abstract][Full Text] [Related]
34. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P.
Ezzahiri R; Stassen FR; Kurvers HR; Dolmans V; Kitslaar PJ; Bruggeman CA
APMIS; 2006 Feb; 114(2):117-26. PubMed ID: 16519748
[TBL] [Abstract][Full Text] [Related]
35. The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease.
Szulakowski P; Crowther AJ; Jiménez LA; Donaldson K; Mayer R; Leonard TB; MacNee W; Drost EM
Am J Respir Crit Care Med; 2006 Jul; 174(1):41-50. PubMed ID: 16574938
[TBL] [Abstract][Full Text] [Related]
36. Markers of Chlamydia pneumoniae and human cytomegalovirus infection in patients with chronic peripheral vascular disease and their relation to inflammation, endothelial dysfunction and changes in lipid metabolism.
Kraml PJ; Roubalová K; Bulvas M; Sommerová Z; PotoCková J; Mandys V; Andel M
Folia Microbiol (Praha); 2008; 53(6):551-7. PubMed ID: 19381484
[TBL] [Abstract][Full Text] [Related]
37. Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease.
Clementsen P; Permin H; Norn S
J Investig Allergol Clin Immunol; 2002; 12(2):73-9. PubMed ID: 12371533
[TBL] [Abstract][Full Text] [Related]
38. Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.
Wizel B; Starcher BC; Samten B; Chroneos Z; Barnes PF; Dzuris J; Higashimoto Y; Appella E; Sette A
J Immunol; 2002 Sep; 169(5):2524-35. PubMed ID: 12193722
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial Defense of Human Airway Epithelial Cells from Chronic Obstructive Pulmonary Disease Patients Induced by Acute Exposure to Nontypeable Haemophilus influenzae: Modulation by Cigarette Smoke.
Amatngalim GD; Schrumpf JA; Henic A; Dronkers E; Verhoosel RM; Ordonez SR; Haagsman HP; Fuentes ME; Sridhar S; Aarbiou J; Janssen RAJ; Lekkerkerker AN; Hiemstra PS
J Innate Immun; 2017; 9(4):359-374. PubMed ID: 28171878
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.
Park SJ; Lee YC; Rhee YK; Lee HB
J Korean Med Sci; 2005 Apr; 20(2):225-8. PubMed ID: 15831991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
